BioPharmGuy logo
Sponsored By:
Trianni Inc.
Weekly Update Subscription
Emery Pharma
EUROIMMUN is defunct.

Fate: Acquired by PerkinElmer, Dec 2017, $1.3B


------------------
If you believe any of this information is incorrect, please let us know.